 |
PDBsum entry 1nub
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Extracellular module
|
PDB id
|
|
|
|
1nub
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Extracellular module
|
 |
|
Title:
|
 |
Helix c deletion mutant of bm-40 fs-ec domain pair
|
|
Structure:
|
 |
Basement membrane protein bm-40. Chain: a, b. Fragment: fs-ec domain pair, fs, follistatin-like, ec, extracellular calcium-binding. Synonym: osteonectin, sparc, secreted protein acidic and rich in cysteine. Engineered: yes. Mutation: yes. Other_details: helix c (residues 196-203) deletion mutant
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Cell_line: 293-ebna. Organ: kidney. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: 293-ebna
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.255
|
R-free:
|
0.306
|
|
|
Authors:
|
 |
E.Hohenester,T.Sasaki,R.Timpl
|
Key ref:
|
 |
T.Sasaki
et al.
(1998).
Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin.
Embo J,
17,
1625-1634.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
05-Dec-97
|
Release date:
|
30-Dec-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P09486
(SPRC_HUMAN) -
SPARC from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
303 a.a.
226 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Embo J
17:1625-1634
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin.
|
|
T.Sasaki,
E.Hohenester,
W.Göhring,
R.Timpl.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The extracellular calcium-binding domain (positions 138-286) of the matrix
protein BM-40 possesses a binding epitope of moderate affinity for several
collagen types. This epitope was predicted to reside in helix alphaA and to be
partially masked by helix alphaC. Here we show that deletion of helix alphaC
produces a 10-fold increase in collagen affinity similar to that seen after
proteolytic cleavage of this helix. The predicted removal of the steric
constraint was clearly demonstrated by the crystal structure of the mutant at
2.8 A resolution. This constitutively activated mutant was used to map the
collagen-binding site following alanine mutagenesis at 13 positions. Five
residues were crucial for binding, R149 and N156 in helix alphaA, and L242, M245
and E246 in a loop region connecting the two EF hands of BM-40. These residues
are spatially close and form a flat ring of 15 A diameter which matches the
diameter of a triple-helical collagen domain. The mutations showed similar
effects on binding to collagens I and IV, indicating nearly identical binding
sites on both collagens. Selected mutations in the non-activated mutant DeltaI
also reduced collagen binding, consistent with the same location of the epitope
but in a more cryptic form in intact BM-40.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2 Structure of BM-40 I,
C.
(A) Two orthogonal views (Kraulis, 1991) related by a rotation
of 90° about the vertical axis. The FS domain is in green and
the EC domain is in red. The calcium ions bound to the EF hand
pair in the EC domain (Ca1 and Ca2) are in yellow; the calcium
ion bound at the tip of the E
- F
loop (Ca3) is in blue. Helices in the EC domain are labelled.
Note that five residues around the deletion site (marked by a
|
 |
Figure 3.
Figure 3 Stereo view (Kraulis, 1991) of a C[ ]trace
of the BM-40 I,
C
structure showing the residues that were mutated in this study
(see text). Disulfide bridges are shown with thick bonds.
Mutated residues are identified by position numbers and their
side chains. The three calcium ions are shown as black spheres.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
Embo J
(1998,
17,
1625-1634)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
F.Brellier,
S.Ruggiero,
D.Zwolanek,
E.Martina,
D.Hess,
M.Brown-Luedi,
U.Hartmann,
M.Koch,
A.Merlo,
M.Lino,
and
R.Chiquet-Ehrismann
(2011).
SMOC1 is a tenascin-C interacting protein over-expressed in brain tumors.
|
| |
Matrix Biol,
30,
225-233.
|
 |
|
|
|
|
 |
S.Y.Chun,
H.J.Lee,
Y.A.Choi,
K.M.Kim,
S.H.Baek,
H.S.Park,
J.Y.Kim,
J.M.Ahn,
J.Y.Cho,
D.W.Cho,
H.I.Shin,
and
E.K.Park
(2011).
Analysis of the soluble human tooth proteome and its ability to induce dentin/tooth regeneration.
|
| |
Tissue Eng Part A,
17,
181-191.
|
 |
|
|
|
|
 |
A.Chlenski,
and
S.L.Cohn
(2010).
Modulation of matrix remodeling by SPARC in neoplastic progression.
|
| |
Semin Cell Dev Biol,
21,
55-65.
|
 |
|
|
|
|
 |
K.Kos,
and
J.P.Wilding
(2010).
SPARC: a key player in the pathologies associated with obesity and diabetes.
|
| |
Nat Rev Endocrinol,
6,
225-235.
|
 |
|
|
|
|
 |
M.S.Clark,
M.A.Thorne,
F.A.Vieira,
J.C.Cardoso,
D.M.Power,
and
L.S.Peck
(2010).
Insights into shell deposition in the Antarctic bivalve Laternula elliptica: gene discovery in the mantle transcriptome using 454 pyrosequencing.
|
| |
BMC Genomics,
11,
362.
|
 |
|
|
|
|
 |
S.A.Arnold,
L.B.Rivera,
A.F.Miller,
J.G.Carbon,
S.P.Dineen,
Y.Xie,
D.H.Castrillon,
E.H.Sage,
P.Puolakkainen,
A.D.Bradshaw,
and
R.A.Brekken
(2010).
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.
|
| |
Dis Model Mech,
3,
57-72.
|
 |
|
|
|
|
 |
A.Koehler,
S.Desser,
B.Chang,
J.MacDonald,
U.Tepass,
and
M.Ringuette
(2009).
Molecular evolution of SPARC: absence of the acidic module and expression in the endoderm of the starlet sea anemone, Nematostella vectensis.
|
| |
Dev Genes Evol,
219,
509-521.
|
 |
|
|
|
|
 |
I.Boutet,
D.Jollivet,
B.Shillito,
D.Moraga,
and
A.Tanguy
(2009).
Molecular identification of differentially regulated genes in the hydrothermal-vent species Bathymodiolus thermophilus and Paralvinella pandorae in response to temperature.
|
| |
BMC Genomics,
10,
222.
|
 |
|
|
|
|
 |
M.M.Phelan,
C.T.Thai,
D.C.Soares,
R.T.Ogata,
P.N.Barlow,
and
J.Bramham
(2009).
Solution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric Arrangement.
|
| |
J Biol Chem,
284,
19637-19649.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.A.Arnold,
and
R.A.Brekken
(2009).
SPARC: a matricellular regulator of tumorigenesis.
|
| |
J Cell Commun Signal,
3,
255-273.
|
 |
|
|
|
|
 |
S.Liao,
M.Ngiam,
C.K.Chan,
and
S.Ramakrishna
(2009).
Fabrication of nano-hydroxyapatite/collagen/osteonectin composites for bone graft applications.
|
| |
Biomed Mater,
4,
25019.
|
 |
|
|
|
|
 |
C.Giudici,
N.Raynal,
H.Wiedemann,
W.A.Cabral,
J.C.Marini,
R.Timpl,
H.P.Bächinger,
R.W.Farndale,
T.Sasaki,
and
R.Tenni
(2008).
Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens.
|
| |
J Biol Chem,
283,
19551-19560.
|
 |
|
|
|
|
 |
E.Hohenester,
T.Sasaki,
C.Giudici,
R.W.Farndale,
and
H.P.Bächinger
(2008).
Structural basis of sequence-specific collagen recognition by SPARC.
|
| |
Proc Natl Acad Sci U S A,
105,
18273-18277.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.M.Weimer,
A.Stanco,
J.G.Cheng,
A.C.Vargo,
S.Voora,
and
E.S.Anton
(2008).
A BAC transgenic mouse model to analyze the function of astroglial SPARCL1 (SC1) in the central nervous system.
|
| |
Glia,
56,
935-941.
|
 |
|
|
|
|
 |
S.Arnold,
E.Mira,
S.Muneer,
G.Korpanty,
A.W.Beck,
S.E.Holloway,
S.Mañes,
and
R.A.Brekken
(2008).
Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC.
|
| |
Exp Biol Med (Maywood),
233,
860-873.
|
 |
|
|
|
|
 |
J.Srivastava,
S.Premi,
S.Kumar,
I.Parwez,
and
S.Ali
(2007).
Characterization of Smoc-1 uncovers two transcript variants showing differential tissue and age specific expression in Bubalus bubalis.
|
| |
BMC Genomics,
8,
436.
|
 |
|
|
|
|
 |
C.F.Delostrinos,
A.E.Hudson,
W.C.Feng,
J.Kosman,
and
J.A.Bassuk
(2006).
The C-terminal Ca2+-binding domain of SPARC confers anti-spreading activity to human urothelial cells.
|
| |
J Cell Physiol,
206,
211-220.
|
 |
|
|
|
|
 |
N.Gersdorff,
M.Müller,
A.Schall,
and
N.Miosge
(2006).
Secreted modular calcium-binding protein-1 localization during mouse embryogenesis.
|
| |
Histochem Cell Biol,
126,
705-712.
|
 |
|
|
|
|
 |
R.O.Emerson,
E.H.Sage,
J.G.Ghosh,
and
J.I.Clark
(2006).
Chaperone-like activity revealed in the matricellular protein SPARC.
|
| |
J Cell Biochem,
98,
701-705.
|
 |
|
|
|
|
 |
T.A.Mason,
P.J.McIlroy,
and
D.H.Shain
(2006).
Structural model of an antistasin/notch-like fusion protein from the cocoon wall of the aquatic leech, Theromyzon tessulatum.
|
| |
J Mol Model,
12,
829-834.
|
 |
|
|
|
|
 |
Y.H.Chun,
Y.Yamakoshi,
J.W.Kim,
T.Iwata,
J.C.Hu,
and
J.P.Simmer
(2006).
Porcine SPARC: isolation from dentin, cDNA sequence, and computer model.
|
| |
Eur J Oral Sci,
114,
78.
|
 |
|
|
|
|
 |
A.Guweidhi,
J.Kleeff,
H.Adwan,
N.A.Giese,
M.N.Wente,
T.Giese,
M.W.Büchler,
M.R.Berger,
and
H.Friess
(2005).
Osteonectin influences growth and invasion of pancreatic cancer cells.
|
| |
Ann Surg,
242,
224-234.
|
 |
|
|
|
|
 |
C.E.Tye,
G.K.Hunter,
and
H.A.Goldberg
(2005).
Identification of the type I collagen-binding domain of bone sialoprotein and characterization of the mechanism of interaction.
|
| |
J Biol Chem,
280,
13487-13492.
|
 |
|
|
|
|
 |
A.Francki,
T.D.McClure,
R.A.Brekken,
K.Motamed,
C.Murri,
T.Wang,
and
E.H.Sage
(2004).
SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
|
| |
J Cell Biochem,
91,
915-925.
|
 |
|
|
|
|
 |
H.O.Hambrock,
B.Kaufmann,
S.Müller,
F.G.Hanisch,
K.Nose,
M.Paulsson,
P.Maurer,
and
U.Hartmann
(2004).
Structural characterization of TSC-36/Flik: analysis of two charge isoforms.
|
| |
J Biol Chem,
279,
11727-11735.
|
 |
|
|
|
|
 |
A.Francki,
K.Motamed,
T.D.McClure,
M.Kaya,
C.Murri,
D.J.Blake,
J.G.Carbon,
and
E.H.Sage
(2003).
SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
|
| |
J Cell Biochem,
88,
802-811.
|
 |
|
|
|
|
 |
A.L.Boskey,
D.J.Moore,
M.Amling,
E.Canalis,
and
A.M.Delany
(2003).
Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls.
|
| |
J Bone Miner Res,
18,
1005-1011.
|
 |
|
|
|
|
 |
B.Leitinger
(2003).
Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2.
|
| |
J Biol Chem,
278,
16761-16769.
|
 |
|
|
|
|
 |
H.O.Hambrock,
D.P.Nitsche,
U.Hansen,
P.Bruckner,
M.Paulsson,
P.Maurer,
and
U.Hartmann
(2003).
SC1/hevin. An extracellular calcium-modulated protein that binds collagen I.
|
| |
J Biol Chem,
278,
11351-11358.
|
 |
|
|
|
|
 |
S.Schenk,
and
V.Quaranta
(2003).
Tales from the crypt[ic] sites of the extracellular matrix.
|
| |
Trends Cell Biol,
13,
366-375.
|
 |
|
|
|
|
 |
C.Vannahme,
N.Smyth,
N.Miosge,
S.Gösling,
C.Frie,
M.Paulsson,
P.Maurer,
and
U.Hartmann
(2002).
Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes.
|
| |
J Biol Chem,
277,
37977-37986.
|
 |
|
|
|
|
 |
G.A.Di Lullo,
S.M.Sweeney,
J.Korkko,
L.Ala-Kokko,
and
J.D.San Antonio
(2002).
Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen.
|
| |
J Biol Chem,
277,
4223-4231.
|
 |
|
|
|
|
 |
X.Zhou,
F.K.Tan,
J.D.Reveille,
D.Wallis,
D.M.Milewicz,
C.Ahn,
A.Wang,
and
F.C.Arnett
(2002).
Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
|
| |
Arthritis Rheum,
46,
2990-2999.
|
 |
|
|
|
|
 |
G.E.Davis,
K.J.Bayless,
M.J.Davis,
and
G.A.Meininger
(2000).
Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.
|
| |
Am J Pathol,
156,
1489-1498.
|
 |
|
|
|
|
 |
A.Francki,
A.D.Bradshaw,
J.A.Bassuk,
C.C.Howe,
W.G.Couser,
and
E.H.Sage
(1999).
SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.
|
| |
J Biol Chem,
274,
32145-32152.
|
 |
|
|
|
|
 |
C.Vannahme,
S.Schübel,
M.Herud,
S.Gösling,
H.Hülsmann,
M.Paulsson,
U.Hartmann,
and
P.Maurer
(1999).
Molecular cloning of testican-2: defining a novel calcium-binding proteoglycan family expressed in brain.
|
| |
J Neurochem,
73,
12-20.
|
 |
|
|
|
|
 |
D.G.Myszka
(1999).
Survey of the 1998 optical biosensor literature.
|
| |
J Mol Recognit,
12,
390-408.
|
 |
|
|
|
|
 |
M.Hopf,
W.Göhring,
E.Kohfeldt,
Y.Yamada,
and
R.Timpl
(1999).
Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.
|
| |
Eur J Biochem,
259,
917-925.
|
 |
|
|
|
|
 |
T.Kamata,
R.C.Liddington,
and
Y.Takada
(1999).
Interaction between collagen and the alpha(2) I-domain of integrin alpha(2)beta(1). Critical role of conserved residues in the metal ion-dependent adhesion site (MIDAS) region.
|
| |
J Biol Chem,
274,
32108-32111.
|
 |
|
|
|
|
 |
T.Sasaki,
N.Fukai,
K.Mann,
W.Göhring,
B.R.Olsen,
and
R.Timpl
(1998).
Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin.
|
| |
EMBO J,
17,
4249-4256.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |